Trial Profile
A phase IIb study evaluating oxymetazoline gel [RDD-0315] for the treatment of fecal incontinence
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2020
Price :
$35
*
At a glance
- Drugs Oxymetazoline (Primary)
- Indications Faecal incontinence
- Focus Therapeutic Use
- 14 Feb 2019 According to an RDD Pharma media release, this trial is expected to start later this year.
- 12 Jan 2016 New trial record
- 07 Jan 2016 According to an RDD Pharma media release, this trial is expected to start in late 2016.